Liquidia CORP Form 4 insider transactions

NASDAQ
Caligan Partners LP reports a series of transactions involving Liquidia Corp common stock, including an in-kind distribution to limited partners and transactions between Caligan Funds.
NASDAQ
Liquidia Corp's Chief Business Officer, Jason Adair, reports the vesting and sale of restricted stock units (RSUs) and shares.
NASDAQ
Liquidia Corp's General Counsel, Russell Schundler, reports acquisition and disposal of company stock, including transactions related to vested restricted stock units and sales under a Rule 10b5-1 plan.
NASDAQ
Chief Commercial Officer Scott Moomaw of Liquidia Corp reports acquisition and disposal of common stock and restricted stock units.
NASDAQ
Liquidia Corp's CFO, Michael Kaseta, reports the acquisition and disposal of common stock and restricted stock units.
NASDAQ
Jason Adair, Chief Business Officer of Liquidia Corp, sold 1,833 shares of common stock on July 26, 2024, to cover taxes associated with the settlement of RSUs.
NASDAQ
Rajeev Saggar, Chief Medical Officer of Liquidia Corp, sold 1,873 shares of common stock to cover taxes associated with the settlement of restricted stock units.
NASDAQ
Liquidia Corp CEO Roger Jeffs sold 8,053 shares of common stock on July 12, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
Liquidia Corp's Chief Commercial Officer, Scott Moomaw, sold shares to cover taxes associated with the settlement of restricted stock units.
NASDAQ
Liquidia Corp's Chief Business Officer, Jason Adair, reports the vesting and sale of restricted stock units (RSUs) to cover taxes.
NASDAQ
Russell Schundler, General Counsel of Liquidia Corp, sold 1,985 shares of common stock on July 12, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
Rajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling shares to cover taxes related to the settlement of restricted stock units.
NASDAQ
Liquidia Corp's CFO, Michael Kaseta, sold 3,906 shares of common stock on July 12, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
Director Raman Singh acquired 20,359 shares of Liquidia Corp through restricted stock units (RSUs) that vest within one year.
NASDAQ
Katherine Rielly-Gauvin, a director of Liquidia Corp, reported the acquisition of 20,359 common stock units on June 20, 2024.
NASDAQ
Director Paul B. Manning reports acquisition of Liquidia Corp stock through restricted stock units and details beneficial ownership.
NASDAQ
Director Arthur Kirsch acquired shares and restricted stock units (RSUs) in Liquidia Corp on June 20, 2024.
NASDAQ
David Edward Johnson, a director and 10% owner of Liquidia Corp, reports the acquisition of restricted stock units convertible to common stock.
NASDAQ
Director Joanna Horobin reports acquisition of 20,359 shares of Liquidia Corp common stock through restricted stock units.
NASDAQ
Director Damian deGoa acquired 20,359 shares of Liquidia Corp common stock on June 20, 2024, as part of a restricted stock unit grant.
NASDAQ
Director Stephen M. Bloch acquired 20,359 shares of Liquidia Corp common stock on June 20, 2024, through restricted stock units.
NASDAQ
Liquidia Corp's CFO, Michael Kaseta, reports the vesting and sale of restricted stock units (RSUs) and common stock transactions.
NASDAQ
Chief Business Officer Jason Adair of Liquidia Corp reports the vesting and sale of common stock to cover taxes.
NASDAQ
Liquidia Corp's General Counsel, Russell Schundler, reports acquisition and disposal of company stock, including transactions to cover taxes on vested RSUs.
NASDAQ
Liquidia Corp's Chief Commercial Officer, Scott Moomaw, reports the vesting and subsequent sale of common stock to cover taxes, alongside other holdings.
NASDAQ
Rajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling 1,649 shares of common stock on April 19, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
Russell Schundler, General Counsel of Liquidia Corp, sold 2,060 shares of common stock on April 12, 2024, to cover taxes associated with the settlement of RSUs.
NASDAQ
Rajeev Saggar, Chief Medical Officer of Liquidia Corp, reports selling 1,525 shares of common stock to cover taxes associated with the settlement of restricted stock units.
NASDAQ
Liquidia Corp's Chief Commercial Officer, Scott Moomaw, sold 1,585 shares of common stock on April 12, 2024, to cover taxes associated with the settlement of restricted stock units.
NASDAQ
Liquidia Corp's CFO, Michael Kaseta, sold 3,136 shares of common stock on April 12, 2024, to cover taxes associated with the settlement of RSUs.